A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma TRYbeCA-1 ¿ TRial of erYaspase in pancreatic CAncer
Clinical Trial Grant
Awarded By
ERYTECH Pharma
Start Date
October 29, 2019
End Date
July 31, 2023
Awarded By
ERYTECH Pharma
Start Date
October 29, 2019
End Date
July 31, 2023